Effect of ibanphosphate combined with chemotherapy on inflammatory factors and bone metabolism indicators in non-small cell lung cancer patients with bone metastasis

XU Yang; LI Hongyun; SU Dan; SHI Ming; YOU Ge; HE Bo

doi:10.7619/jcmp.20213459

Journal of Clinical Medicine in Practice > 2022 > 26(2): 52-55. > DOI: 10.7619/jcmp.20213459

XU Yang, LI Hongyun, SU Dan, SHI Ming, YOU Ge, HE Bo. Effect of ibanphosphate combined with chemotherapy on inflammatory factors and bone metabolism indicators in non-small cell lung cancer patients with bone metastasis[J]. Journal of Clinical Medicine in Practice, 2022, 26(2): 52-55. DOI: 10.7619/jcmp.20213459

Citation:

PDF (544 KB)

Effect of ibanphosphate combined with chemotherapy on inflammatory factors and bone metabolism indicators in non-small cell lung cancer patients with bone metastasis

XU Yang¹,
LI Hongyun¹,
SU Dan¹,
SHI Ming¹,
YOU Ge²,
HE Bo^1, ,

1.
Department of Oncology, the Third Medical Center of General Hospital of Chinese People′s Liberation Army, Beijing, 100039
2.
Department of Oncology, People′s Hospital of Ningxia Hui Autonomous Region, Yinchuan, Ningxia, 750002

More Information

Received Date: August 26, 2021
Available Online: March 01, 2022
Published Date: January 27, 2022

Graphical Abstract

Abstract

Abstract

Objective To investigate the effect of ibanphosphate combined with chemotherapy on inflammatory factors and bone metabolism indicators in non-small cell lung cancer(NSCLC) patients with bone metastasis.
Methods A total of 120 NSCLC patients with bone metastasis were included in this study. Patients with lung adenocarcinoma were treated with pemetrexed, carboplatin combined with ibandronate sodium, and those with lung squamous cell carcinoma were treated with paclitaxel liposome for injection or albumin paclitaxel for injection, all patients underwent 2 cycles of chemotherapy. The levels of inflammatory factors such as serum C-reactive protein (CRP), procalcitonin (PCT), tumor necrosis factor (TNF-α), interleukin-6 (IL-6), bone metabolic indexes such as amino intermediate fragment of osteocalcin, amino terminal peptide of type Ⅰ procollagen, carboxy terminal peptide of type Ⅰ collagen β special sequence, bone specific alkaline phosphatase, bone pain score and incidence of adverse reactions were compared before and after chemotherapy.
Results After 2 cycles of chemotherapy, the levels of CRP, PCT, TNF-α, IL-6 and the carboxy terminal peptide of type Ⅰ collagen β special sequence were significantly lower than those before chemotherapy, amino intermediate fragment of osteocalcin, amino terminal peptide of type Ⅰ procollagen and bone specific alkaline phosphatase were significantly higher than those before chemotherapy(P < 0.05). The score of bone pain was (15.56±3.89) before chemotherapy and (2.47±1.79) after 2 cycles of chemotherapy, and the score of bone pain after 2 cycles of chemotherapy was significantly lower than that before chemotherapy (P < 0.05). There were 8 cases of fever, 10 cases of nausea, 13 cases of vomiting and 7 cases of bone marrow suppression, with the incidence of adverse reactions of 31.67%.
Conclusion Ibanphosphate combined with chemotherapy can significantly reduce the level of serum inflammatory factors in NSCLC patients with bone metastasis, improve the serum bone metabolism indexes, and has good application safety.
- non-small cell lung cancer,
- bone metastasis,
- ibanphosphate,
- chemotherapy,
- inflammatory factors,
- bone metabolism indexes

FullText(HTML)

References (20)

References

[1]	YE Y, LUO Z, SHI D. Use of cell free DNA as a prognostic biomarker in non-small cell lung cancer patients with bone metastasis[J]. Int J Biol Markers, 2019, 34(4): 381-388. doi: 10.1177/1724600819854452
[2]	PONTAROLLO G, CONFAVREUX C B, PIALAT J B, et al. Bone decalcification to assess programmed cell death ligand 1 expression in bone metastases of non-small cell lung cancers[J]. J Bone Oncol, 2020, 21: 100275. doi: 10.1016/j.jbo.2020.100275
[3]	XU S, CAO S, GENG J, et al. High prognostic nutritional index (PNI) as a positive prognostic indicator for non-small cell lung cancer patients with bone metastasis[J]. Clin Respir J, 2020, 15(2): 225-231.
[4]	CHEN Y Y, WANG P P, YANG F, et al. Inferior outcome of bone metastasis in patients with non-small cell lung cancer treated with epidermal growth factor receptor inhibitors[J]. J Bone Oncol, 2021, 13(6): 1203-1208.
[5]	HANSEL K, MARIETTI R, TRAMONTANA M, et al. Sensitization/tolerance profile of betamethasone sodium phosphate in patients with contact allergy to budesonide[J]. Dermatol Ther, 2020, 33(6): e14155.
[6]	TAKAMORI S, TAKADA K, SHIMOKAWA M, et al. Clinical utility of pretreatment Glasgow prognostic score in non-small-cell lung cancer patients treated with immune checkpoint inhibitors[J]. Lung Cancer Amsterdam Neth, 2021, 152: 27-33. doi: 10.1016/j.lungcan.2020.11.026
[7]	MORA VALLELLANO J, DELGADO PECELLÍN C, DELGADO PECELLÍN I, et al. Evaluation of bone metabolism in children with cystic fibrosis[J]. Bone, 2021, 147: 115929. doi: 10.1016/j.bone.2021.115929
[8]	许尧, 张超, 郭旭, 等. 肺癌不同病理类型与骨转移临床特征相关性研究[J]. 中华骨科杂志, 2019, 39(6): 329-335.
[9]	王伟. 唑来膦酸对晚期非小细胞肺癌骨转移患者的疗效及VEGF-C和COX2水平的影响[J]. 医学临床研究, 2019, 36(4): 640-642. doi: 10.3969/j.issn.1671-7171.2019.04.006
[10]	WANG X, LOU Z, ZHANG L, et al. Evaluation of the prognostic value of derived neutrophil/lymphocyte ratio in early stage non-small cell lung cancer patients treated with stereotactic ablative radiotherapy[J]. Medicine: Baltimore, 2020, 99(42): e22603. doi: 10.1097/MD.0000000000022603
[11]	YAO D, HUANG L, KE J, et al. Bone metabolism regulation: implications for the treatment of bone diseases[J]. Biomed Pharmacother, 2020, 129: 110494. doi: 10.1016/j.biopha.2020.110494
[12]	潘文斌, 何伟岳. 不同放化疗方式治疗非小细胞肺癌骨转移效果比较[J]. 中华老年医学杂志, 2019, 38(12): 1353-1356. doi: 10.3760/cma.j.issn.0254-9026.2019.12.008
[13]	YANG X R, PI C, YU R, et al. Correlation of exosomal microRNA clusters with bone metastasis in non-small cell lung cancer[J]. Clin Exp Metastasis, 2021, 38(1): 109-117. doi: 10.1007/s10585-020-10062-y
[14]	中华医学会病理学分会, 国家病理质控中心, 中华医学会肿瘤学分会肺癌学组, 等. 非小细胞肺癌分子病理检测临床实践指南(2021版)[J]. 中华病理学杂志, 2021, 50(4): 323-332. doi: 10.3760/cma.j.cn112151-20201220-00945
[15]	IONTA F Q, DOS SANTOS N M, MESQUITA I M, et al. Is the dentifrice containing calcium silicate, sodium phosphate, and fluoride able to protect enamel against chemical mechanical wear An in situ/ex vivo study[J]. Clin Oral Investig, 2019, 23(10): 3713-3720. doi: 10.1007/s00784-018-2792-4
[16]	陈滔, 谭兴春. 唑来膦酸联合化疗对非小细胞肺癌骨转移临床疗效及炎性因子水平的影响[J]. 药物评价研究, 2019, 42(6): 1198-1201. https://www.cnki.com.cn/Article/CJFDTOTAL-YWPJ201906028.htm
[17]	CHARRIER M, MEZQUITA L, LUEZA B, et al. Circulating innate immune markers and outcomes in treatment-naÏve advanced non-small cell lung cancer patients[J]. Eur J Cancer, 2019, 108: 88-96. doi: 10.1016/j.ejca.2018.12.017
[18]	KOBAYASHI S, KARUBE Y, MATSUMURA Y, et al. Inflammatory risk factors for early recurrence of non-small cell lung cancer within one year following curative resection[J]. World J Surg, 2020, 44(10): 3510-3521. doi: 10.1007/s00268-020-05612-0
[19]	SUDJARITRUK T, BUNUPURADAH T, AURPIBUL L, et al. Impact of vitamin D and calcium supplementation on bone mineral density and bone metabolism among Thai adolescents with perinatally acquired human immunodeficiency virus (HIV) infection: a randomized clinical trial[J]. Clin Infect Dis, 2021, 73(9): 1555-1564. doi: 10.1093/cid/ciab547
[20]	EHNERT S, RINDERKNECHT H, ASPERA-WERZ R H, et al. Use of in vitro bone models to screen for altered bone metabolism, osteopathies, and fracture healing: challenges of complex models[J]. Arch Toxicol, 2020, 94(12): 3937-3958. doi: 10.1007/s00204-020-02906-z

Cited By

Cited by

Periodical cited type(4)

1.	陶梦珂，李苗苗，石晴晴，赵恒，张鲁星，胡功政，潘玉善，刘建华. 鸡源大肠杆菌生物被膜形成与耐药性、毒力基因的关联性分析. 畜牧与兽医. 2024(06): 86-93 .
2.	高远，袁志浩，王永鑫，辛文成，乔保平. 八宝丹胶囊预防导尿管相关性尿路感染的效果. 郑州大学学报(医学版). 2024(05): 701-703 .
3.	林秀慧，许政衡，林秀华，王诗佳，张娇珍. 老年导尿管相关尿路感染生物被膜菌分布特征及生物被膜形成相关基因. 中华医院感染学杂志. 2023(05): 718-722 .
4.	袁杭海，马志芳，唐补生，郭华伟，张海春，丁一波. 尿路感染的现代研究和中医治疗进展. 河北中医. 2023(07): 1199-1202 .

Other cited types(2)

Get Citation

PDF

XML

Article views PDF downloads Cited by(6)

Turn off MathJax

Article Contents

Abstract

References

Effect of ibanphosphate combined with chemotherapy on inflammatory factors and bone metabolism indicators in non-small cell lung cancer patients with bone metastasis

Abstract

References

Cited by

Periodical cited type(4)

Other cited types(2)

Catalog

Export File

Citation

Format

Content